U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 040015

Expand all

NEOSAR (CYCLOPHOSPHAMIDE)
100MG/VIAL
Marketing Status: Discontinued
Active Ingredient: CYCLOPHOSPHAMIDE
Proprietary Name: NEOSAR
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 100MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A040015
Product Number: 001
Approval Date: Apr 29, 1993
Applicant Holder Full Name: TEVA PARENTERAL MEDICINES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
NEOSAR (CYCLOPHOSPHAMIDE)
200MG/VIAL
Marketing Status: Discontinued
Active Ingredient: CYCLOPHOSPHAMIDE
Proprietary Name: NEOSAR
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 200MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A040015
Product Number: 002
Approval Date: Apr 29, 1993
Applicant Holder Full Name: TEVA PARENTERAL MEDICINES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
NEOSAR (CYCLOPHOSPHAMIDE)
500MG/VIAL
Marketing Status: Discontinued
Active Ingredient: CYCLOPHOSPHAMIDE
Proprietary Name: NEOSAR
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 500MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A040015
Product Number: 003
Approval Date: Apr 29, 1993
Applicant Holder Full Name: TEVA PARENTERAL MEDICINES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
NEOSAR (CYCLOPHOSPHAMIDE)
1GM/VIAL
Marketing Status: Discontinued
Active Ingredient: CYCLOPHOSPHAMIDE
Proprietary Name: NEOSAR
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1GM/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A040015
Product Number: 004
Approval Date: Apr 29, 1993
Applicant Holder Full Name: TEVA PARENTERAL MEDICINES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
NEOSAR (CYCLOPHOSPHAMIDE)
2GM/VIAL
Marketing Status: Discontinued
Active Ingredient: CYCLOPHOSPHAMIDE
Proprietary Name: NEOSAR
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2GM/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A040015
Product Number: 005
Approval Date: Apr 29, 1993
Applicant Holder Full Name: TEVA PARENTERAL MEDICINES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top